Black Infusions Receives Superb Wine Enthusiast Ratings for Black Fig and Gold Apricot Vodkas
Both spirits brands are rated higher than any other vodka in 2020. Boston, MA, January 29, 2021 (PR.com) Craft spirits company Black Infusions announced the award of 96- and 94-point reviews from the internationally recognized team at Wine Enthusiast magazine. Black Infusions Black Fig and Gold Apricot are rated among the top 5% of more than 700 vodkas reviewed on the Wine Enthusiast website.
The 96-point rating of Gold Apricot is three points higher than the publication’s top rated vodka of 2020. Wine Enthusiast ratings of 94-97 points highlight Superb spirits within its guide of more than 280,000 products. The tastings are performed blind, with products tasted by experts in peer-group flights.
Share this article
Share this article
LEXINGTON, Ky., Jan. 26, 2021 /PRNewswire/ The following is a letter from Maj. Gen. Michael Davidson, Asst. Chairman Joint Chiefs (Ret.), U.S. Medical Glove Company.
Today President Biden issued an executive order titled Ensuring the Future Is Made in All of America by All of America s Workers
This is why I am leading the investment of hundreds of millions of dollars to build Liberty Glove project to create the largest domestic network of high-technology nitrile glove factories right here in America.
This will create thousands of American jobs, expanding the industrial base for nitrile examination gloves while using massive budgets created by our tax dollars to develop plant-based polymer examination gloves for the safety of Americans.
Staff Report
photo by: Nick Krug
Michael Davidson, the director of Explore Lawrence, is pictured outside the Lawrence Public Library on Thursday, June 9, 2016.
The director of the city’s visitors bureau has announced his upcoming retirement.
Explore Lawrence Director Michael Davidson will retire in the spring, according to a news release. Davidson ends his career after thirty plus years in leadership roles in the tourism industry, including leading tourism bureaus in Long Island, N.Y. and Walla Walla, Wash. He has led the Lawrence visitors bureau since April 2016.
During his tenure, the visitors bureau’s operating budget increased by about 30%, the organization opened a visitors center on Massachusetts Street in downtown Lawrence, and most recently Davidson helped administer a grants program for hospitality businesses negatively impacted by the COVID-19 pandemic.
MORRISVILLE –Tenax Therameputics is acquiring an Illinois-based biotech firm with a promising hypertension treatment and named that company’s cofounder as its chief medical officer.
Tenax (Nasdaq: TENX) shares soared 38% to $2.45 shortly after the announced deal for PH Precision Med (PHPM) and the appointment of Stuart Rich, MD, as its CMO early Tuesday.
Tenax is paying some 12 million shares of stock to PHPM shareholders.
PHPM is focused on a potential treatment of pulmonary arterial hypertension, and its lead candidate has received Orphan Drug Designation from the FDA. The drug – a “Pase 3 [clinical trial] candidate” – has the “potential to be the first disease modifying treatment of pulmonary arterial hypertension,” Tenax explained.
NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program
NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program NewAmsterdam Pharma (NAP), a clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases, today announced completion of a $196M (‚¬160M) Series A funding round. The financing will support the full Phase 3 development of its ApoB and LDL-c lowering small molecule drug, obicetrapib. The drug, a cholesteryl ester transfer protein (CETP) inhibitor, is being developed for patients who are not well-controlled on statins. Forbion, NAPs founding investor, was joined by Morningside Ventures and Ascendant BioCapital as co-lead investors in the Series A financing. Also participating in this funding round were Kaiser Foundation Hospitals, BVF Partners L.P., Population Health Partners, LSP Dementia Fund, Peter